Have therapeutic measures improved the prognosis of operable breast cancer? Adjuvant chemotherapy
Senn, H.J.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 91: 421-428
1985
ISSN/ISBN: 0070-4067 PMID: 4090642 Document Number: 250495
Document emailed within 1 workday
Related Documents
Rossi, A.; Valagussa, P.; Bonadonna, G. 1977: Surgery and adjuvant chemotherapy in the treatment of operable breast cancer Progress in Clinical and Biological Research 12: 391-404Leonard, J.P. 2003: Improved outcomes from dose-dense adjuvant chemotherapy for breast cancer with growth factor support Current Hematology Reports 2(6): 451-452
O'Brien, P.H. 1976: Adjuvant treatment in operable breast cancer Journal of the South Carolina Medical Association 72(5): 173-174
Hudis, C.A.; Norton, L. 1996: Adjuvant drug therapy for operable breast cancer Seminars in Oncology 23(4): 475-493
Zhang, P.; Hou, W.; Yang, Z. 1997: Prognosis of premenopausal patients with operable breast cancer related to the timing of operation Zhonghua Zhong Liu Za Zhi 19(4): 281-283
Zhang, B.; Zhang, Q. 2007: Neoadjuvant systemic chemotherapy for patients with operable breast cancer Zhonghua Zhong Liu Za Zhi 29(3): 161-165
Conti, F.; Sergi, D.; Foggi, P.; Abbate, M.I.; Lopez, M. 2007: New combination chemotherapy regimens in the primary treatment of operable breast cancer La Clinica Terapeutica 158(1): 55-75
Franceschini, G.; Di Leone, A.; Natale, M.; Sanchez, M.A.; Masett, R. 2018: Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer Annali Italiani di Chirurgia 89: 290
Schuuring, E.; Verhoeven, E.; van Tinteren, H.; Peterse, J.L.; Nunnink, B.; Thunnissen, F.B.; Devilee, P.; Cornelisse, C.J.; van de Vijver, M.J.; Mooi, W.J. 1992: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer Cancer Research 52(19): 5229-5234
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
2006: Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group Anticancer Research 26(1b): 591-597
Von Heyden, H.W. 2000: The evaluation of therapeutic results as exemplified by the adjuvant chemotherapy of breast carcinoma Deutsche Medizinische Wochenschrift 125(11): 340
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Kennedy, B.J. 1979: Adjuvant chemotherapy of breast cancer Minnesota Medicine 62(7): 509-511
Singhal, N.; Bapsy, P.P. 2003: Breast cancer and adjuvant chemotherapy National Medical Journal of India 16(4): 214-215
Rouëssé, J.; May-Levin, F.; Sarrazin, D.; Petit, J.Y. 1978: Adjuvant chemotherapy of breast cancer La Revue du Praticien 28(13): 977-983
Semiglazov, V.F.; Golubeva, O.M.; Bavli, I.L.; Ivanova, O.A.; Topuzov, E.E. 1992: The adjuvant chemotherapy of breast cancer Voprosy Onkologii 38(10): 1187-1194
Mattheiem, W.; Philippon, R.; Heuson, J.C. 1971: Adjuvant chemotherapy in breast cancer Acta Chirurgica Belgica Suppl 1: 105-111
Evans, R.A. 1995: Adjuvant chemotherapy in breast cancer New England Journal of Medicine 333(9): 596-597
Cleton, F.J.; Engelsman, E.; Nooy, M. 1986: Adjuvant therapy in patients with operable breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 130(16): 719-721